Content about Tums

February 13, 2013
Tums Freshers voted 2013 Product of the Year in the OTC relief category in TNS survey

GlaxoSmithKline Consumer Healthcare North America on Wednesday announced that its Tums Freshers was voted 2013 Product of the Year in the OTC relief category as part of a survey of more than 50,000 people conducted by global research firm TNS.

PARSIPPANY, N.J. — GlaxoSmithKline Consumer Healthcare North America on Wednesday announced that its Tums Freshers was voted 2013 Product of the Year in the OTC relief category as part of a survey of more than 50,000 people conducted by global research firm TNS.

August 17, 2012
Generics contend in PPIs

Procter & Gamble’s Prilosec OTC still is the best-selling antacid on the market, with more than $252.7 million in annual sales for the 52 weeks ended July 8 across food, drug and mass (excluding Walmart), followed by fellow proton-pump inhibitor Novartis’ Prevacid 24HR ($104.1 million).


Procter & Gamble’s Prilosec OTC still is the best-selling antacid on the market, with more than $252.7 million in annual sales for the 52 weeks ended July 8 across food, drug and mass (excluding Walmart), followed by fellow proton-pump inhibitor Novartis’ Prevacid 24HR ($104.1 million).


Both of those antacid heavy hitters are losing dollar share to their generic-
equivalent competitors, however, leaving GlaxoSmithKline’s venerable Tums brand as the largest growth brand within antacids ($91.3 million in sales, up 2.5%).


March 26, 2012
Tums touts a ‘fresh’ take

Tums has proven to be the Houdini of digestive tablets — surviving all digestive switch products from H2 blockers through proton-pump inhibitors, and still growing.

Tums has proven to be the Houdini of digestive tablets — surviving all digestive switch products from H2 blockers through proton-pump inhibitors, and still growing. For the 12 weeks ended Jan. 12, sales of Tums were up more than 3%, and it still was among the top three antacids.


March 5, 2012
Tums battles heartburn, bad breath with new smaller-size tablet

GlaxoSmithKline Consumer Healthcare North America on Monday launched Tums Freshers, a new tablet-size version of Tums that is 40% smaller than regular Tums and includes a cooling flavor for breath freshening.

PARSIPPANY, N.J. — GlaxoSmithKline Consumer Healthcare North America on Monday launched Tums Freshers, a new tablet-size version of Tums that is 40% smaller than regular Tums and includes a cooling flavor for breath freshening.

October 11, 2011
‘Regular’ sales increases

Sales in the digestives aisle going forward look positive, especially as an aging population begins paying closer attention to healthy diets, including the right amount of dietary fiber to keep things “regular” and supplementation with probiotics for overall digestive health.


Sales in the digestives aisle going forward look positive, especially as an aging population begins paying closer attention to healthy diets, including the right amount of dietary fiber to keep things “regular” and supplementation with probiotics for overall digestive health.


July 25, 2011
Wellness drives sales in digestives, probiotics

Sales in the digestives aisle going forward look positive, especially as an aging population begins paying closer attention to healthy diets, including the right amount of dietary fiber to keep things “regular” and supplementation with probiotics for overall digestive health. 


Sales in the digestives aisle going forward look positive, especially as an aging population begins paying closer attention to healthy diets, including the right amount of dietary fiber to keep things “regular” and supplementation with probiotics for overall digestive health. 


June 20, 2011
Three’s not a crowd: Top antacids hold their own


Good things come in three — like the three antacids that for the 52 weeks ended April 17 collectively generated more than $118 million in sales on top of the sales base they had established in the year-ago period.



Good things come in three — like the three antacids that for the 52 weeks ended April 17 collectively generated more than $118 million in sales on top of the sales base they had established in the year-ago period.


March 4, 2011
PPIs time out to Tums

NEW YORK — Sure, the plethora of proton-pump inhibitors dotting digestive aisles these days have generated plenty of buzz among antacids, but what do heartburn sufferers do while they wait for the PPI to begin working? They turn to an immediate relief option like the Tums and Tums Ultra brands, which together generated growth of 96.3% to $24.9 million for the 12 weeks ended Jan. 23 across food, drug and mass (minus Walmart), according to SymphonyIRI Group data.

December 7, 2010
P&G, GSK hold their own 
in crowded antacid aisle

NEW YORK — Last year, the big question on every­one’s mind was: How many brands can actually thrive in what has become a cluttered antacid shelf? Because just exactly how many heartburn sufferers are there?


March 14, 2010
Antacids take over airwaves to protect share of stomach

By the end of this quarter, there shouldn’t be one person in America who doesn’t...

December 3, 2009
Zegerid OTC approved as heartburn remedy

The digestives aisle will be altogether crowded come early 2010, especially with two new proton-pump...

NEW YORK The digestives aisle will be altogether crowded come early 2010, especially with two new proton-pump inhibitors on the shelf. And while there may be some question as to just how large sales of antacids can get, one thing is for sure: There will be a slew of advertisers vying for their own increased share of stomach.